Attached files
| file | filename |
|---|---|
| 10-K - Sucampo Pharmaceuticals, Inc. | v213743_10k.htm |
| EX-32.1 - Sucampo Pharmaceuticals, Inc. | v213743_ex32-1.htm |
| EX-31.1 - Sucampo Pharmaceuticals, Inc. | v213743_ex31-1.htm |
| EX-32.2 - Sucampo Pharmaceuticals, Inc. | v213743_ex32-2.htm |
| EX-10.49 - Sucampo Pharmaceuticals, Inc. | v213743_ex10-49.htm |
| EX-31.2 - Sucampo Pharmaceuticals, Inc. | v213743_ex31-2.htm |
| EX-10.50 - Sucampo Pharmaceuticals, Inc. | v213743_ex10-50.htm |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-147420) of Sucampo Pharmaceuticals, Inc. of our report dated March 8, 2011 relating to the financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Baltimore, Maryland
March 8, 2011